PropertyValue
nif:beginIndex
  • 0 (xsd:integer)
nif:broaderContext
nif:endIndex
  • 129 (xsd:integer)
nif:isString
  • Cisplatin-based chemotherapy is recommended in both the neoadjuvant and first-line setting, with response rates up to ~50% [3,4].
rdf:type